1. Home
  2. NVCT vs ACR Comparison

NVCT vs ACR Comparison

Compare NVCT & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • ACR
  • Stock Information
  • Founded
  • NVCT 2020
  • ACR 2005
  • Country
  • NVCT United States
  • ACR United States
  • Employees
  • NVCT N/A
  • ACR N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • ACR Real Estate Investment Trusts
  • Sector
  • NVCT Health Care
  • ACR Real Estate
  • Exchange
  • NVCT Nasdaq
  • ACR Nasdaq
  • Market Cap
  • NVCT 119.4M
  • ACR 127.9M
  • IPO Year
  • NVCT 2022
  • ACR N/A
  • Fundamental
  • Price
  • NVCT $4.90
  • ACR $16.74
  • Analyst Decision
  • NVCT Strong Buy
  • ACR Buy
  • Analyst Count
  • NVCT 1
  • ACR 2
  • Target Price
  • NVCT $21.00
  • ACR $17.50
  • AVG Volume (30 Days)
  • NVCT 303.6K
  • ACR 24.3K
  • Earning Date
  • NVCT 11-05-2024
  • ACR 10-30-2024
  • Dividend Yield
  • NVCT N/A
  • ACR N/A
  • EPS Growth
  • NVCT N/A
  • ACR N/A
  • EPS
  • NVCT N/A
  • ACR 0.83
  • Revenue
  • NVCT N/A
  • ACR $77,437,000.00
  • Revenue This Year
  • NVCT N/A
  • ACR N/A
  • Revenue Next Year
  • NVCT N/A
  • ACR N/A
  • P/E Ratio
  • NVCT N/A
  • ACR $20.12
  • Revenue Growth
  • NVCT N/A
  • ACR 8.77
  • 52 Week Low
  • NVCT $4.69
  • ACR $7.31
  • 52 Week High
  • NVCT $12.10
  • ACR $16.93
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 35.71
  • ACR 64.88
  • Support Level
  • NVCT $4.75
  • ACR $16.03
  • Resistance Level
  • NVCT $5.49
  • ACR $16.81
  • Average True Range (ATR)
  • NVCT 1.14
  • ACR 0.36
  • MACD
  • NVCT -0.52
  • ACR 0.09
  • Stochastic Oscillator
  • NVCT 3.02
  • ACR 87.82

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: